Access to medicines as a human right :: implications for pharmaceutical industry responsibility /
"According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Toronto :
University of Toronto Press,
[2012]
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | "According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health? This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue"--Provided by publisher |
| Beschreibung: | 1 online resource (vi, 214 pages) |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 9781442661127 1442661127 1442698276 9781442698277 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBU-ocn868069010 | ||
| 003 | OCoLC | ||
| 005 | 20240405112445.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 140114s2012 onc ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d OCLCQ |d EBLCP |d AGLDB |d MERUC |d OCLCQ |d OCLCA |d OCLCQ |d STF |d OCLCQ |d OCLCO |d OCLCA |d VLB |d VLY |d OCLCA |d OCLCQ |d OCLCO |d OCL |d OCLCQ |d OCLCO |d INARC |d OCLCL | ||
| 016 | |z 20129022411 (print) | ||
| 019 | |a 1162394014 | ||
| 020 | |a 9781442661127 |q (electronic bk.) | ||
| 020 | |a 1442661127 |q (electronic bk.) | ||
| 020 | |a 1442698276 | ||
| 020 | |a 9781442698277 | ||
| 020 | |z 9781442643970 | ||
| 020 | |z 1442643978 | ||
| 035 | |a (OCoLC)868069010 |z (OCoLC)1162394014 | ||
| 050 | 4 | |a HD9665.5 |b .A27 2012eb | |
| 055 | 1 | 0 | |a HD9665.5 |b A24 2012 |
| 055 | 1 | 0 | |a HD9665 .5 |b A33 2012 |
| 060 | 4 | |a 2012 H-513 | |
| 060 | 4 | |a QV 21 | |
| 072 | 7 | |a BUS |x 008000 |2 bisacsh | |
| 082 | 7 | |a 174.2/951 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Access to medicines as a human right : |b implications for pharmaceutical industry responsibility / |c edited by Lisa Forman and Jillian Clare Kohler. |
| 264 | 1 | |a Toronto : |b University of Toronto Press, |c [2012] | |
| 264 | 4 | |c ©2012 | |
| 300 | |a 1 online resource (vi, 214 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | 0 | |g Introduction : |t access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? / |r Lisa Forman and Jillian Clare Kohler -- |t Human rights responsibilities of pharmaceutical companies in relation to access to medicines / |t Rajat Khosla and Paul Hunt -- |t Improving access to essential medicines : international law and normative change / |r Asher Alkoby -- |t Corporate social responsibility and the right to essential medicines / |r Patricia Illingworth -- |t Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility / |r Matthew Lee and Jillian Clare Kohler -- |t Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? / |r Joel Lexchin -- |t Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform / |r Richard Eilliott -- |t Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa / |r Judith King and Stephanie Nixon -- |g Annex : |t human rights guidelines for pharmaceutical companies in relation to access to medicines. |
| 520 | |a "According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health? | ||
| 520 | |a This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue"--Provided by publisher | ||
| 588 | 0 | |a Print version record. | |
| 546 | |a English. | ||
| 650 | 0 | |a Pharmaceutical industry |x Moral and ethical aspects. | |
| 650 | 0 | |a Pharmaceutical ethics. |0 http://id.loc.gov/authorities/subjects/sh85100584 | |
| 650 | 0 | |a Human rights |x Health aspects. | |
| 650 | 0 | |a Social responsibility of business. |0 http://id.loc.gov/authorities/subjects/sh90005735 | |
| 650 | 0 | |a Human rights. |0 http://id.loc.gov/authorities/subjects/sh85026379 | |
| 650 | 1 | 2 | |a Drug Industry |x ethics |
| 650 | 2 | 2 | |a Health Services Accessibility |x ethics |
| 650 | 2 | 2 | |a Human Rights |
| 650 | 2 | 2 | |a Social Responsibility |
| 650 | 2 | |a Ethics, Pharmacy |0 https://id.nlm.nih.gov/mesh/D004994 | |
| 650 | 6 | |a Industrie pharmaceutique |x Aspect moral. | |
| 650 | 6 | |a Pharmaciens |x Déontologie. | |
| 650 | 6 | |a Droits de l'homme (Droit international) |x Aspect sanitaire. | |
| 650 | 6 | |a Entreprises |x Responsabilité sociale. | |
| 650 | 6 | |a Droits de l'homme (Droit international) | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Business Ethics. |2 bisacsh | |
| 650 | 7 | |a Human rights |2 fast | |
| 650 | 7 | |a Human rights |x Health aspects |2 fast | |
| 650 | 7 | |a Pharmaceutical ethics |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |x Moral and ethical aspects |2 fast | |
| 650 | 7 | |a Social responsibility of business |2 fast | |
| 700 | 1 | |a Forman, Lisa, |d 1970- |1 https://id.oclc.org/worldcat/entity/E39PBJfWVBQgvrW4Y98jq8B3wC |0 http://id.loc.gov/authorities/names/no2012139746 | |
| 700 | 1 | |a Kohler, Jillian Clare. | |
| 758 | |i has work: |a Access to medicines as a human right (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGv8FgKbMD8PKhXtwBRRJC |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Access to medicines as a human right |z 9781442643970 |w (DLC) 2012406607 |w (OCoLC)791161904 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBU |q FWS_PDA_EBU |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=682866 |3 Volltext |
| 938 | |a Internet Archive |b INAR |n isbn_9781442643970 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL4672976 | ||
| 938 | |a EBSCOhost |b EBSC |n 682866 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBU | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBU-ocn868069010 |
|---|---|
| _version_ | 1804748444413198336 |
| adam_text | |
| any_adam_object | |
| author2 | Forman, Lisa, 1970- Kohler, Jillian Clare |
| author2_role | |
| author2_variant | l f lf j c k jc jck |
| author_GND | http://id.loc.gov/authorities/names/no2012139746 |
| author_additional | Lisa Forman and Jillian Clare Kohler -- Asher Alkoby -- Patricia Illingworth -- Matthew Lee and Jillian Clare Kohler -- Joel Lexchin -- Richard Eilliott -- Judith King and Stephanie Nixon -- |
| author_facet | Forman, Lisa, 1970- Kohler, Jillian Clare |
| author_sort | Forman, Lisa, 1970- |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | H - Social Science |
| callnumber-label | HD9665 |
| callnumber-raw | HD9665.5 .A27 2012eb |
| callnumber-search | HD9665.5 .A27 2012eb |
| callnumber-sort | HD 49665.5 A27 42012EB |
| callnumber-subject | HD - Industries, Land Use, Labor |
| collection | ZDB-4-EBU |
| contents | access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? / Human rights responsibilities of pharmaceutical companies in relation to access to medicines / Rajat Khosla and Paul Hunt -- Improving access to essential medicines : international law and normative change / Corporate social responsibility and the right to essential medicines / Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility / Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? / Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform / Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa / human rights guidelines for pharmaceutical companies in relation to access to medicines. |
| ctrlnum | (OCoLC)868069010 |
| dewey-full | 174.2/951 |
| dewey-hundreds | 100 - Philosophy & psychology |
| dewey-ones | 174 - Occupational ethics |
| dewey-raw | 174.2/951 |
| dewey-search | 174.2/951 |
| dewey-sort | 3174.2 3951 |
| dewey-tens | 170 - Ethics (Moral philosophy) |
| discipline | Philosophie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05900cam a2200829 i 4500</leader><controlfield tag="001">ZDB-4-EBU-ocn868069010</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20240405112445.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">140114s2012 onc ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">VLB</subfield><subfield code="d">VLY</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">INARC</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1=" " ind2=" "><subfield code="z">20129022411 (print)</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1162394014</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781442661127</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1442661127</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1442698276</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781442698277</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781442643970</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1442643978</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)868069010</subfield><subfield code="z">(OCoLC)1162394014</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HD9665.5</subfield><subfield code="b">.A27 2012eb</subfield></datafield><datafield tag="055" ind1="1" ind2="0"><subfield code="a">HD9665.5</subfield><subfield code="b">A24 2012</subfield></datafield><datafield tag="055" ind1="1" ind2="0"><subfield code="a">HD9665 .5</subfield><subfield code="b">A33 2012</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2012 H-513</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QV 21</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">BUS</subfield><subfield code="x">008000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">174.2/951</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Access to medicines as a human right :</subfield><subfield code="b">implications for pharmaceutical industry responsibility /</subfield><subfield code="c">edited by Lisa Forman and Jillian Clare Kohler.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Toronto :</subfield><subfield code="b">University of Toronto Press,</subfield><subfield code="c">[2012]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (vi, 214 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="g">Introduction :</subfield><subfield code="t">access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? /</subfield><subfield code="r">Lisa Forman and Jillian Clare Kohler --</subfield><subfield code="t">Human rights responsibilities of pharmaceutical companies in relation to access to medicines /</subfield><subfield code="t">Rajat Khosla and Paul Hunt --</subfield><subfield code="t">Improving access to essential medicines : international law and normative change /</subfield><subfield code="r">Asher Alkoby --</subfield><subfield code="t">Corporate social responsibility and the right to essential medicines /</subfield><subfield code="r">Patricia Illingworth --</subfield><subfield code="t">Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility /</subfield><subfield code="r">Matthew Lee and Jillian Clare Kohler --</subfield><subfield code="t">Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? /</subfield><subfield code="r">Joel Lexchin --</subfield><subfield code="t">Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform /</subfield><subfield code="r">Richard Eilliott --</subfield><subfield code="t">Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa /</subfield><subfield code="r">Judith King and Stephanie Nixon --</subfield><subfield code="g">Annex :</subfield><subfield code="t">human rights guidelines for pharmaceutical companies in relation to access to medicines.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health?</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue"--Provided by publisher</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical ethics.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85100584</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Human rights</subfield><subfield code="x">Health aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Social responsibility of business.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh90005735</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Human rights.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85026379</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Drug Industry</subfield><subfield code="x">ethics</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Health Services Accessibility</subfield><subfield code="x">ethics</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Human Rights</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Social Responsibility</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Ethics, Pharmacy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004994</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Industrie pharmaceutique</subfield><subfield code="x">Aspect moral.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Pharmaciens</subfield><subfield code="x">Déontologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Droits de l'homme (Droit international)</subfield><subfield code="x">Aspect sanitaire.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Entreprises</subfield><subfield code="x">Responsabilité sociale.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Droits de l'homme (Droit international)</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS</subfield><subfield code="x">Business Ethics.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human rights</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human rights</subfield><subfield code="x">Health aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical ethics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Social responsibility of business</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Forman, Lisa,</subfield><subfield code="d">1970-</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJfWVBQgvrW4Y98jq8B3wC</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2012139746</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kohler, Jillian Clare.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Access to medicines as a human right (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGv8FgKbMD8PKhXtwBRRJC</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Access to medicines as a human right</subfield><subfield code="z">9781442643970</subfield><subfield code="w">(DLC) 2012406607</subfield><subfield code="w">(OCoLC)791161904</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBU</subfield><subfield code="q">FWS_PDA_EBU</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=682866</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">isbn_9781442643970</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL4672976</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">682866</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBU</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBU-ocn868069010 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-16T15:03:58Z |
| institution | BVB |
| isbn | 9781442661127 1442661127 1442698276 9781442698277 |
| language | English |
| oclc_num | 868069010 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (vi, 214 pages) |
| psigel | ZDB-4-EBU |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | University of Toronto Press, |
| record_format | marc |
| spelling | Access to medicines as a human right : implications for pharmaceutical industry responsibility / edited by Lisa Forman and Jillian Clare Kohler. Toronto : University of Toronto Press, [2012] ©2012 1 online resource (vi, 214 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references. Introduction : access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? / Lisa Forman and Jillian Clare Kohler -- Human rights responsibilities of pharmaceutical companies in relation to access to medicines / Rajat Khosla and Paul Hunt -- Improving access to essential medicines : international law and normative change / Asher Alkoby -- Corporate social responsibility and the right to essential medicines / Patricia Illingworth -- Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility / Matthew Lee and Jillian Clare Kohler -- Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? / Joel Lexchin -- Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform / Richard Eilliott -- Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa / Judith King and Stephanie Nixon -- Annex : human rights guidelines for pharmaceutical companies in relation to access to medicines. "According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health? This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue"--Provided by publisher Print version record. English. Pharmaceutical industry Moral and ethical aspects. Pharmaceutical ethics. http://id.loc.gov/authorities/subjects/sh85100584 Human rights Health aspects. Social responsibility of business. http://id.loc.gov/authorities/subjects/sh90005735 Human rights. http://id.loc.gov/authorities/subjects/sh85026379 Drug Industry ethics Health Services Accessibility ethics Human Rights Social Responsibility Ethics, Pharmacy https://id.nlm.nih.gov/mesh/D004994 Industrie pharmaceutique Aspect moral. Pharmaciens Déontologie. Droits de l'homme (Droit international) Aspect sanitaire. Entreprises Responsabilité sociale. Droits de l'homme (Droit international) BUSINESS & ECONOMICS Business Ethics. bisacsh Human rights fast Human rights Health aspects fast Pharmaceutical ethics fast Pharmaceutical industry Moral and ethical aspects fast Social responsibility of business fast Forman, Lisa, 1970- https://id.oclc.org/worldcat/entity/E39PBJfWVBQgvrW4Y98jq8B3wC http://id.loc.gov/authorities/names/no2012139746 Kohler, Jillian Clare. has work: Access to medicines as a human right (Text) https://id.oclc.org/worldcat/entity/E39PCGv8FgKbMD8PKhXtwBRRJC https://id.oclc.org/worldcat/ontology/hasWork Print version: Access to medicines as a human right 9781442643970 (DLC) 2012406607 (OCoLC)791161904 FWS01 ZDB-4-EBU FWS_PDA_EBU https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=682866 Volltext |
| spellingShingle | Access to medicines as a human right : implications for pharmaceutical industry responsibility / access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? / Human rights responsibilities of pharmaceutical companies in relation to access to medicines / Rajat Khosla and Paul Hunt -- Improving access to essential medicines : international law and normative change / Corporate social responsibility and the right to essential medicines / Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility / Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? / Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform / Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa / human rights guidelines for pharmaceutical companies in relation to access to medicines. Pharmaceutical industry Moral and ethical aspects. Pharmaceutical ethics. http://id.loc.gov/authorities/subjects/sh85100584 Human rights Health aspects. Social responsibility of business. http://id.loc.gov/authorities/subjects/sh90005735 Human rights. http://id.loc.gov/authorities/subjects/sh85026379 Drug Industry ethics Health Services Accessibility ethics Human Rights Social Responsibility Ethics, Pharmacy https://id.nlm.nih.gov/mesh/D004994 Industrie pharmaceutique Aspect moral. Pharmaciens Déontologie. Droits de l'homme (Droit international) Aspect sanitaire. Entreprises Responsabilité sociale. Droits de l'homme (Droit international) BUSINESS & ECONOMICS Business Ethics. bisacsh Human rights fast Human rights Health aspects fast Pharmaceutical ethics fast Pharmaceutical industry Moral and ethical aspects fast Social responsibility of business fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85100584 http://id.loc.gov/authorities/subjects/sh90005735 http://id.loc.gov/authorities/subjects/sh85026379 https://id.nlm.nih.gov/mesh/D004994 |
| title | Access to medicines as a human right : implications for pharmaceutical industry responsibility / |
| title_alt | access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? / Human rights responsibilities of pharmaceutical companies in relation to access to medicines / Rajat Khosla and Paul Hunt -- Improving access to essential medicines : international law and normative change / Corporate social responsibility and the right to essential medicines / Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility / Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? / Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform / Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa / human rights guidelines for pharmaceutical companies in relation to access to medicines. |
| title_auth | Access to medicines as a human right : implications for pharmaceutical industry responsibility / |
| title_exact_search | Access to medicines as a human right : implications for pharmaceutical industry responsibility / |
| title_full | Access to medicines as a human right : implications for pharmaceutical industry responsibility / edited by Lisa Forman and Jillian Clare Kohler. |
| title_fullStr | Access to medicines as a human right : implications for pharmaceutical industry responsibility / edited by Lisa Forman and Jillian Clare Kohler. |
| title_full_unstemmed | Access to medicines as a human right : implications for pharmaceutical industry responsibility / edited by Lisa Forman and Jillian Clare Kohler. |
| title_short | Access to medicines as a human right : |
| title_sort | access to medicines as a human right implications for pharmaceutical industry responsibility |
| title_sub | implications for pharmaceutical industry responsibility / |
| topic | Pharmaceutical industry Moral and ethical aspects. Pharmaceutical ethics. http://id.loc.gov/authorities/subjects/sh85100584 Human rights Health aspects. Social responsibility of business. http://id.loc.gov/authorities/subjects/sh90005735 Human rights. http://id.loc.gov/authorities/subjects/sh85026379 Drug Industry ethics Health Services Accessibility ethics Human Rights Social Responsibility Ethics, Pharmacy https://id.nlm.nih.gov/mesh/D004994 Industrie pharmaceutique Aspect moral. Pharmaciens Déontologie. Droits de l'homme (Droit international) Aspect sanitaire. Entreprises Responsabilité sociale. Droits de l'homme (Droit international) BUSINESS & ECONOMICS Business Ethics. bisacsh Human rights fast Human rights Health aspects fast Pharmaceutical ethics fast Pharmaceutical industry Moral and ethical aspects fast Social responsibility of business fast |
| topic_facet | Pharmaceutical industry Moral and ethical aspects. Pharmaceutical ethics. Human rights Health aspects. Social responsibility of business. Human rights. Drug Industry ethics Health Services Accessibility ethics Human Rights Social Responsibility Ethics, Pharmacy Industrie pharmaceutique Aspect moral. Pharmaciens Déontologie. Droits de l'homme (Droit international) Aspect sanitaire. Entreprises Responsabilité sociale. Droits de l'homme (Droit international) BUSINESS & ECONOMICS Business Ethics. Human rights Human rights Health aspects Pharmaceutical ethics Pharmaceutical industry Moral and ethical aspects Social responsibility of business |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=682866 |
| work_keys_str_mv | AT formanlisa accesstomedicinesasahumanrightimplicationsforpharmaceuticalindustryresponsibility AT kohlerjillianclare accesstomedicinesasahumanrightimplicationsforpharmaceuticalindustryresponsibility |